Premium
P3–325: Troglitazone, a peroxisome proliferator–activated receptor– agonist, decreases tau phosphorylation in chotau4r cells
Author(s) -
d'Abramo Cristina,
Davies Peter
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.1595
Subject(s) - troglitazone , thiazolidinedione , phosphorylation , protein kinase b , pi3k/akt/mtor pathway , chemistry , microbiology and biotechnology , peroxisome proliferator activated receptor , neurodegeneration , phosphoinositide 3 kinase , cytosol , kinase , endocrinology , receptor , medicine , signal transduction , biology , biochemistry , type 2 diabetes , diabetes mellitus , disease , enzyme